Skip to content
Screener

AYTU BioPharma, Inc. AYTU Q4 2024 earnings

Reported February 12, 2025 · After market close

Revenue$16.2MMiss by $1.4M
EPS-$0.28In line
Revenue estimate$17.6M
EPS estimate-$0.28

Next report

Sep 29, 2026 (in a month)
Revenue estimate$12.3M
EPS estimate-$0.29

FAQ

When did AYTU BioPharma, Inc. report Q4 2024 earnings?
AYTU BioPharma, Inc. (AYTU) reported Q4 2024 earnings on February 12, 2025 after market close.
What were AYTU BioPharma, Inc.'s Q4 2024 revenue and EPS?
AYTU BioPharma, Inc. reported revenue of $16.2M and eps of $-0.28 for Q4 2024.
Did AYTU BioPharma, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $17.6M by $1.4M. EPS beat the consensus estimate of $-0.28 by $0.00.
Where can I find AYTU BioPharma, Inc.'s Q4 2024 SEC filings?
You can read the 8-K earnings release (0001437749-25-003563) and the 10-Q periodic report (0001437749-25-003568) directly on SEC EDGAR. The filing index links above go to sec.gov.